HUP0102662A2 - Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom - Google Patents

Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

Info

Publication number
HUP0102662A2
HUP0102662A2 HU0102662A HUP0102662A HUP0102662A2 HU P0102662 A2 HUP0102662 A2 HU P0102662A2 HU 0102662 A HU0102662 A HU 0102662A HU P0102662 A HUP0102662 A HU P0102662A HU P0102662 A2 HUP0102662 A2 HU P0102662A2
Authority
HU
Hungary
Prior art keywords
nitrogen atom
heterocyclic ring
membered heterocyclic
ring containing
imidazoylalkyl
Prior art date
Application number
HU0102662A
Other languages
Hungarian (hu)
Inventor
Robert G. Aslanian
John J. Piwinski
Stuart B. Rosenblum
Daniel M. Solomon
Wayne D. Vaccaro
Ronald L. Wolin
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0102662A2 publication Critical patent/HUP0102662A2/en
Publication of HUP0102662A3 publication Critical patent/HUP0102662A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0102662A 1997-11-07 1998-11-05 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom HUP0102662A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96575497A 1997-11-07 1997-11-07
PCT/US1998/023224 WO1999024421A1 (en) 1997-11-07 1998-11-05 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

Publications (2)

Publication Number Publication Date
HUP0102662A2 true HUP0102662A2 (en) 2001-12-28
HUP0102662A3 HUP0102662A3 (en) 2003-01-28

Family

ID=25510440

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102662A HUP0102662A3 (en) 1997-11-07 1998-11-05 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom

Country Status (12)

Country Link
EP (1) EP1028956A1 (en)
JP (1) JP2001522845A (en)
KR (1) KR20010031839A (en)
CN (1) CN1285828A (en)
AR (1) AR016671A1 (en)
AU (1) AU1296799A (en)
CA (1) CA2309609A1 (en)
HU (1) HUP0102662A3 (en)
IL (1) IL135727A0 (en)
PE (1) PE130699A1 (en)
WO (1) WO1999024421A1 (en)
ZA (1) ZA9810186B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140337A (en) * 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
FR2827863A1 (en) * 2001-07-27 2003-01-31 Sanofi Synthelabo New dihydropyrrolyl alkyl imidazole derivatives having histamine receptor antagonist activity for treatment of obesity, diabetes, and central nervous system disorders
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
WO2005058823A1 (en) * 2003-12-17 2005-06-30 Takeda Pharmaceutical Company Limited Urea derivative, process for producing the same, and use
NZ590148A (en) * 2004-12-30 2012-04-27 Janssen Pharmaceutica Nv Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
UA108233C2 (en) 2010-05-03 2015-04-10 Fatty acid amide hydrolysis activity modulators
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
WO2022175384A1 (en) * 2021-02-17 2022-08-25 Fundación Universidad Católica De Valencia San Vicente Mártir Small-molecule agents with antiviral activity against rna viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9207393A (en) * 1991-12-18 1994-06-30 Schering Corp IMIDAZOIL OR RENT IMIDAZOIL SUBSTITUTED WITH A HETERO-CYCLE CHAIN OF FOUR OR FIVE MEMBERS CONTAINING NITROGEN.
ATE140223T1 (en) * 1991-12-18 1996-07-15 Schering Corp IMIDOLYLALKYL DERIVATIVES SUBSTITUTED WITH A NITROGEN CONTAINING 6-MEMBED RING
AU7823894A (en) * 1993-08-27 1995-03-21 Vrije Universiteit New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor
BR9711149A (en) * 1996-08-16 1999-08-17 Schering Corp Treatment of allergic responses of the upper respiratory tract with a combination of histamine receptor antagonists

Also Published As

Publication number Publication date
PE130699A1 (en) 1999-12-16
IL135727A0 (en) 2001-05-20
WO1999024421A1 (en) 1999-05-20
CA2309609A1 (en) 1999-05-20
WO1999024421A8 (en) 1999-08-26
ZA9810186B (en) 1999-05-06
KR20010031839A (en) 2001-04-16
HUP0102662A3 (en) 2003-01-28
AR016671A1 (en) 2001-07-25
AU1296799A (en) 1999-05-31
EP1028956A1 (en) 2000-08-23
JP2001522845A (en) 2001-11-20
CN1285828A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
EP0616913A3 (en) High-temperature battery.
HK1032005A1 (en) Polymeric derivatives of camptothecins.
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
GB9309716D0 (en) Heterocyclic derivatives
ZA941137B (en) Substitutet azolone derivatives.
ZA9811128B (en) 1,3,8-Triaza-spiro(4,5)decan-4-on derivatives
GB9409948D0 (en) Dibber drills
HU9401766D0 (en) Urea derivatives containing heterocyclic ring
IL109451A0 (en) Heterocyclic derivatives
IL135727A0 (en) Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
EP0710107A4 (en) N,n,n-trimethylsphingosine derivatives
IL108148A0 (en) Toothbrushes, particularly for one-time use
EP0605988A3 (en) A carrier construction.
HU9403465D0 (en) Heterocyclic derivatives
HU9403010D0 (en) Cyclic amine derivatives
GB9313201D0 (en) New heterocyclic compounds
HU9402534D0 (en) New naphtoxazine derivatives
EP0783488A4 (en) Five membered heterocyclic compounds
ZA936048B (en) Novel 3-oxadiazolyl-1,6-napthyridine derivatives
ZA945728B (en) 7-amino-1,1-dioxocefem l-valylamides
HUT71607A (en) N,n-substituted amino-methylen-imidazolinone derivatives
GB9310413D0 (en) Cigarette,cigare extruinguisher
FI930999A0 (en) LAETTBYGGT, LUTNINGSREGLERAT, ICKESTJAELPBART, MED BELYSNING FOERSETT GRAVMONUMENT MED TUNNPLAOTSYTA
FI933919A0 (en) CYLINDRISK BEHAOLLARE, SAOSOM SOLVAERMEACKUMULATORTANK FOERSEDD MED EN SOLFAONGARE